Evidence map›Paper›PMID 31144439›Full record

ArticleJournal of cellular and molecular medicine2019

Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.

Hongda Pan, Jingxin Pan, Shibo Song, Lei Ji, Hong Lv, Zhangru Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hongda PanDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID 0000-0002-5538-051X
Jingxin PanDepartment of Hematology, The Second Attached Hospital of Fujian Medical University, Quanzhou, China.
Shibo SongDepartment of Gastrointestinal Surgery, Beijing Hospital, Beijing, China.
Lei JiDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Hong LvDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhangru YangDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shanghai Medical College of Fudan University · CNFujian Medical University · CNBeijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-associated death globally. Long non-coding RNAs (lncRNAs) have been identified as micro RNA (miRNA) sponges in a competing endogenous RNA (ceRNA) network and are involved in the regulation of mRNA expression. This study aims to construct a lncRNA-associated ceRNA network and investigate the prognostic biomarkers in CRC. A total of 38 differentially expressed (DE) lncRNAs, 23 DEmiRNAs and 27 DEmRNAs were identified by analysing the expression profiles of CRC obtained from The Cancer Genome Atlas (TCGA). These RNAs were chosen to develop a ceRNA regulatory network of CRC, which comprised 125 edges. Survival analysis showed that four lncRNAs, six miRNAs and five mRNAs were significantly associated with overall survival. A potential regulatory axis of ADAMTS9-AS2/miR-32/PHLPP2 was identified from the network. Experimental validation was performed using clinical samples by quantitative real-time PCR (qRT-PCR), which showed that expression of the genes in the axis was associated with clinicopathological features and the correlation among them perfectly conformed to the 'ceRNA theory'. Overexpression of ADAMTS9-AS2 in colon cancer cell lines significantly inhibited the miR-32 expression and promoted PHLPP2 expression, while ADAMTS9-AS2 knockdown had the opposite effects. The constructed novel ceRNA network may provide a comprehensive understanding of the mechanisms of CRC carcinogenesis. The ADAMTS9-AS2/miR-32/PHLPP2 regulatory axis may serve as a potential therapeutic target for CRC.

Indexed as

Biomarkers, TumorColorectal NeoplasmsComputational BiologyFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksHT29 CellsHumansKaplan-Meier EstimateMaleMicroRNAsPhosphoprotein PhosphatasesPrognosisRNA, Long NoncodingRNA, MessengerSurvival AnalysisBiomarkers, TumorlncRNA ADAMTS9-AS2, humanMicroRNAsMIRN32 microRNA, humanPHLPP2 protein, humanPhosphoprotein PhosphatasesRNA, Long NoncodingRNA, Messengerbioinformatics analysiscolorectal cancercompeting endogenous RNAlong non-coding RNAprognostic biomarkerThe Cancer Genome Atlas

Identifiers

PMID31144439
PMCPMC6653593
OpenAlexW2947904233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.